| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Angiography | 275 | 2023 | 866 | 36.180 |
Why?
|
| Tomography, X-Ray Computed | 383 | 2023 | 2324 | 35.950 |
Why?
|
| Coronary Artery Disease | 171 | 2023 | 696 | 27.220 |
Why?
|
| Computed Tomography Angiography | 135 | 2023 | 424 | 24.020 |
Why?
|
| Coronary Stenosis | 81 | 2023 | 246 | 15.170 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 117 | 2020 | 373 | 14.980 |
Why?
|
| Fractional Flow Reserve, Myocardial | 56 | 2022 | 137 | 12.460 |
Why?
|
| Coronary Vessels | 57 | 2022 | 313 | 10.570 |
Why?
|
| Contrast Media | 132 | 2022 | 595 | 10.490 |
Why?
|
| Pulmonary Embolism | 65 | 2018 | 253 | 9.080 |
Why?
|
| Radiation Dosage | 94 | 2020 | 419 | 7.790 |
Why?
|
| Myocardial Perfusion Imaging | 37 | 2022 | 100 | 7.650 |
Why?
|
| Vascular Calcification | 25 | 2022 | 131 | 6.720 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 35 | 2019 | 92 | 6.030 |
Why?
|
| Image Processing, Computer-Assisted | 60 | 2021 | 689 | 5.780 |
Why?
|
| Predictive Value of Tests | 113 | 2023 | 1465 | 5.510 |
Why?
|
| Radiography, Thoracic | 24 | 2022 | 99 | 5.300 |
Why?
|
| Humans | 594 | 2023 | 68618 | 5.300 |
Why?
|
| Radiographic Image Enhancement | 48 | 2018 | 208 | 5.260 |
Why?
|
| Plaque, Atherosclerotic | 29 | 2023 | 125 | 5.120 |
Why?
|
| Machine Learning | 27 | 2022 | 170 | 5.030 |
Why?
|
| Algorithms | 77 | 2022 | 1196 | 4.890 |
Why?
|
| Middle Aged | 301 | 2023 | 21147 | 4.790 |
Why?
|
| Myocardial Ischemia | 24 | 2022 | 172 | 4.650 |
Why?
|
| Artificial Intelligence | 25 | 2023 | 159 | 4.630 |
Why?
|
| Angiography | 38 | 2021 | 194 | 4.560 |
Why?
|
| Reproducibility of Results | 127 | 2021 | 2077 | 4.520 |
Why?
|
| Sensitivity and Specificity | 116 | 2021 | 1753 | 4.470 |
Why?
|
| Male | 373 | 2023 | 37321 | 4.390 |
Why?
|
| Chest Pain | 27 | 2021 | 151 | 4.350 |
Why?
|
| Aortic Valve Stenosis | 19 | 2022 | 177 | 4.270 |
Why?
|
| Female | 359 | 2023 | 38074 | 4.210 |
Why?
|
| Aged | 222 | 2023 | 14862 | 4.180 |
Why?
|
| Iohexol | 35 | 2018 | 82 | 3.980 |
Why?
|
| Retrospective Studies | 158 | 2023 | 7277 | 3.980 |
Why?
|
| Heart | 40 | 2021 | 850 | 3.880 |
Why?
|
| Calcinosis | 35 | 2018 | 241 | 3.850 |
Why?
|
| Electrocardiography | 55 | 2022 | 601 | 3.680 |
Why?
|
| Multidetector Computed Tomography | 18 | 2019 | 60 | 3.650 |
Why?
|
| Coronary Disease | 30 | 2020 | 358 | 3.600 |
Why?
|
| Magnetic Resonance Imaging | 42 | 2022 | 2223 | 3.510 |
Why?
|
| Pulmonary Artery | 27 | 2019 | 323 | 3.430 |
Why?
|
| Transcatheter Aortic Valve Replacement | 15 | 2022 | 90 | 3.220 |
Why?
|
| Heart Valve Prosthesis Implantation | 12 | 2022 | 164 | 3.110 |
Why?
|
| Tomography, Spiral Computed | 20 | 2019 | 57 | 2.900 |
Why?
|
| Heart Diseases | 17 | 2022 | 276 | 2.860 |
Why?
|
| Artifacts | 27 | 2019 | 125 | 2.790 |
Why?
|
| Coronary Circulation | 11 | 2018 | 136 | 2.540 |
Why?
|
| Magnetic Resonance Angiography | 22 | 2022 | 181 | 2.480 |
Why?
|
| Lung Diseases | 11 | 2020 | 175 | 2.440 |
Why?
|
| Imaging, Three-Dimensional | 34 | 2020 | 333 | 2.430 |
Why?
|
| Prospective Studies | 77 | 2022 | 3705 | 2.420 |
Why?
|
| Aortic Valve | 14 | 2022 | 249 | 2.340 |
Why?
|
| Cardiac-Gated Imaging Techniques | 26 | 2019 | 60 | 2.330 |
Why?
|
| Prognosis | 60 | 2023 | 2093 | 2.280 |
Why?
|
| Severity of Illness Index | 56 | 2022 | 1851 | 2.280 |
Why?
|
| Adult | 151 | 2022 | 21403 | 2.220 |
Why?
|
| Aged, 80 and over | 75 | 2022 | 4848 | 2.170 |
Why?
|
| Diagnostic Imaging | 10 | 2018 | 201 | 2.140 |
Why?
|
| Myocardial Infarction | 17 | 2020 | 807 | 2.100 |
Why?
|
| Diagnosis, Computer-Assisted | 7 | 2020 | 75 | 2.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 23 | 2021 | 137 | 2.000 |
Why?
|
| Radiation Protection | 13 | 2016 | 71 | 1.920 |
Why?
|
| Acute Coronary Syndrome | 8 | 2021 | 195 | 1.910 |
Why?
|
| Ventricular Dysfunction, Right | 14 | 2023 | 117 | 1.840 |
Why?
|
| Risk Assessment | 43 | 2021 | 2007 | 1.840 |
Why?
|
| Stents | 13 | 2022 | 657 | 1.810 |
Why?
|
| Echocardiography | 13 | 2022 | 515 | 1.810 |
Why?
|
| Myocardium | 19 | 2022 | 1204 | 1.790 |
Why?
|
| Exercise Test | 12 | 2019 | 242 | 1.780 |
Why?
|
| Magnetic Resonance Imaging, Cine | 19 | 2023 | 83 | 1.750 |
Why?
|
| ROC Curve | 27 | 2020 | 392 | 1.730 |
Why?
|
| Iopamidol | 13 | 2015 | 37 | 1.720 |
Why?
|
| Cardiac Catheterization | 18 | 2022 | 419 | 1.670 |
Why?
|
| Cardiomyopathies | 6 | 2023 | 167 | 1.650 |
Why?
|
| Radiation Injuries | 4 | 2014 | 97 | 1.600 |
Why?
|
| Thoracic Diseases | 4 | 2018 | 10 | 1.560 |
Why?
|
| Heart Valve Prosthesis | 6 | 2021 | 222 | 1.530 |
Why?
|
| Lung | 17 | 2022 | 849 | 1.530 |
Why?
|
| Feasibility Studies | 32 | 2021 | 652 | 1.470 |
Why?
|
| Pulmonary Emphysema | 3 | 2020 | 71 | 1.450 |
Why?
|
| Percutaneous Coronary Intervention | 6 | 2022 | 137 | 1.440 |
Why?
|
| Phantoms, Imaging | 21 | 2023 | 189 | 1.430 |
Why?
|
| Coronary Vessel Anomalies | 8 | 2019 | 45 | 1.360 |
Why?
|
| Lung Neoplasms | 12 | 2021 | 1173 | 1.350 |
Why?
|
| Calcium | 12 | 2022 | 929 | 1.350 |
Why?
|
| Peripheral Arterial Disease | 5 | 2021 | 83 | 1.330 |
Why?
|
| Aorta, Thoracic | 7 | 2021 | 211 | 1.330 |
Why?
|
| Angiography, Digital Subtraction | 8 | 2020 | 63 | 1.280 |
Why?
|
| Observer Variation | 28 | 2018 | 330 | 1.250 |
Why?
|
| Signal-To-Noise Ratio | 24 | 2020 | 93 | 1.200 |
Why?
|
| Coronary Restenosis | 3 | 2017 | 42 | 1.180 |
Why?
|
| Cardiac Imaging Techniques | 7 | 2020 | 35 | 1.180 |
Why?
|
| Periodicals as Topic | 4 | 2019 | 158 | 1.170 |
Why?
|
| Cardiovascular Diseases | 9 | 2019 | 940 | 1.140 |
Why?
|
| Standard of Care | 2 | 2020 | 22 | 1.120 |
Why?
|
| Heart Ventricles | 17 | 2021 | 738 | 1.120 |
Why?
|
| Body Weight | 5 | 2020 | 554 | 1.120 |
Why?
|
| Risk Factors | 42 | 2023 | 5731 | 1.110 |
Why?
|
| Radiation Exposure | 9 | 2019 | 84 | 1.110 |
Why?
|
| Atrial Fibrillation | 5 | 2022 | 249 | 1.090 |
Why?
|
| Hemodynamics | 10 | 2019 | 705 | 1.070 |
Why?
|
| Lower Extremity | 6 | 2020 | 153 | 1.050 |
Why?
|
| Radiometry | 3 | 2012 | 64 | 1.040 |
Why?
|
| Heart Defects, Congenital | 9 | 2019 | 596 | 1.000 |
Why?
|
| Acute Disease | 26 | 2018 | 658 | 0.960 |
Why?
|
| Cost-Benefit Analysis | 10 | 2019 | 504 | 0.950 |
Why?
|
| Atherosclerosis | 6 | 2023 | 204 | 0.950 |
Why?
|
| Multimodal Imaging | 6 | 2022 | 62 | 0.940 |
Why?
|
| Emergency Service, Hospital | 9 | 2020 | 711 | 0.930 |
Why?
|
| Image Interpretation, Computer-Assisted | 13 | 2021 | 237 | 0.930 |
Why?
|
| Aortography | 9 | 2021 | 72 | 0.920 |
Why?
|
| Triiodobenzoic Acids | 7 | 2018 | 28 | 0.920 |
Why?
|
| Coronary Aneurysm | 5 | 2014 | 19 | 0.890 |
Why?
|
| Iodine | 9 | 2021 | 42 | 0.880 |
Why?
|
| Angina, Stable | 4 | 2017 | 13 | 0.880 |
Why?
|
| Photons | 1 | 2022 | 32 | 0.830 |
Why?
|
| Adenosine | 9 | 2016 | 165 | 0.820 |
Why?
|
| Radiography | 5 | 2020 | 572 | 0.800 |
Why?
|
| Patient Care | 1 | 2022 | 61 | 0.800 |
Why?
|
| Pulmonary Circulation | 8 | 2017 | 79 | 0.780 |
Why?
|
| Thorax | 3 | 2023 | 49 | 0.780 |
Why?
|
| Hypertension, Pulmonary | 5 | 2015 | 232 | 0.760 |
Why?
|
| Software | 14 | 2021 | 418 | 0.760 |
Why?
|
| Body Surface Area | 2 | 2021 | 20 | 0.750 |
Why?
|
| Aortic Diseases | 9 | 2019 | 113 | 0.750 |
Why?
|
| Quarantine | 1 | 2020 | 3 | 0.750 |
Why?
|
| Asia | 7 | 2019 | 59 | 0.750 |
Why?
|
| Acute Kidney Injury | 4 | 2017 | 232 | 0.750 |
Why?
|
| Diagnosis, Differential | 21 | 2015 | 1140 | 0.740 |
Why?
|
| Radiologists | 2 | 2022 | 35 | 0.740 |
Why?
|
| Young Adult | 31 | 2021 | 5717 | 0.730 |
Why?
|
| Practice Guidelines as Topic | 7 | 2020 | 772 | 0.730 |
Why?
|
| Area Under Curve | 10 | 2020 | 238 | 0.730 |
Why?
|
| Workflow | 2 | 2020 | 100 | 0.720 |
Why?
|
| Bone Density | 2 | 2023 | 159 | 0.710 |
Why?
|
| Adolescent | 34 | 2021 | 8912 | 0.710 |
Why?
|
| Follow-Up Studies | 23 | 2022 | 3259 | 0.710 |
Why?
|
| Organometallic Compounds | 3 | 2022 | 95 | 0.710 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 123 | 0.690 |
Why?
|
| Body Burden | 4 | 2011 | 27 | 0.690 |
Why?
|
| Internationality | 2 | 2019 | 74 | 0.690 |
Why?
|
| Workload | 1 | 2020 | 103 | 0.690 |
Why?
|
| Decision Making | 3 | 2020 | 410 | 0.690 |
Why?
|
| Journal Impact Factor | 1 | 2019 | 12 | 0.680 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 193 | 0.680 |
Why?
|
| Stroke Volume | 10 | 2023 | 586 | 0.680 |
Why?
|
| Perfusion Imaging | 4 | 2017 | 27 | 0.660 |
Why?
|
| Preoperative Care | 6 | 2021 | 275 | 0.660 |
Why?
|
| Heart Failure | 7 | 2023 | 1180 | 0.660 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2015 | 277 | 0.650 |
Why?
|
| Constriction, Pathologic | 12 | 2023 | 236 | 0.640 |
Why?
|
| Tin | 3 | 2018 | 16 | 0.640 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2018 | 6 | 0.630 |
Why?
|
| Health Care Costs | 4 | 2019 | 346 | 0.620 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2014 | 36 | 0.620 |
Why?
|
| Smokers | 1 | 2020 | 200 | 0.610 |
Why?
|
| Acute Pain | 4 | 2020 | 35 | 0.610 |
Why?
|
| Radiography, Abdominal | 9 | 2017 | 57 | 0.600 |
Why?
|
| Editorial Policies | 1 | 2018 | 32 | 0.600 |
Why?
|
| Aorta | 3 | 2021 | 316 | 0.590 |
Why?
|
| Coronary Artery Bypass | 7 | 2019 | 218 | 0.590 |
Why?
|
| Prevalence | 19 | 2022 | 1619 | 0.590 |
Why?
|
| Europe | 7 | 2019 | 196 | 0.580 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2021 | 134 | 0.580 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 207 | 0.580 |
Why?
|
| Patient Selection | 6 | 2013 | 592 | 0.570 |
Why?
|
| Intracranial Aneurysm | 4 | 2020 | 87 | 0.560 |
Why?
|
| Ventricular Function | 4 | 2012 | 93 | 0.550 |
Why?
|
| Heart Atria | 8 | 2022 | 206 | 0.550 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2014 | 79 | 0.550 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 286 | 0.540 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 130 | 0.530 |
Why?
|
| Nerve Net | 4 | 2021 | 181 | 0.530 |
Why?
|
| Germany | 9 | 2016 | 67 | 0.530 |
Why?
|
| Registries | 8 | 2021 | 733 | 0.520 |
Why?
|
| Forecasting | 5 | 2018 | 277 | 0.520 |
Why?
|
| Meglumine | 1 | 2015 | 16 | 0.510 |
Why?
|
| Statistics, Nonparametric | 12 | 2019 | 306 | 0.510 |
Why?
|
| Postoperative Complications | 5 | 2018 | 1615 | 0.510 |
Why?
|
| Radiology | 5 | 2021 | 97 | 0.510 |
Why?
|
| Myocardial Bridging | 3 | 2019 | 3 | 0.500 |
Why?
|
| Heart Valves | 1 | 2016 | 171 | 0.500 |
Why?
|
| Heart Valve Diseases | 2 | 2022 | 123 | 0.500 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2015 | 41 | 0.500 |
Why?
|
| Lymphocytes | 4 | 2020 | 228 | 0.500 |
Why?
|
| Heart Rate | 10 | 2023 | 568 | 0.500 |
Why?
|
| Adipose Tissue | 6 | 2022 | 221 | 0.490 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2020 | 24 | 0.490 |
Why?
|
| Gadolinium | 7 | 2022 | 88 | 0.490 |
Why?
|
| Evidence-Based Medicine | 9 | 2017 | 438 | 0.490 |
Why?
|
| Diabetic Angiopathies | 1 | 2016 | 203 | 0.490 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 378 | 0.480 |
Why?
|
| Apolipoprotein E4 | 3 | 2021 | 31 | 0.480 |
Why?
|
| Body Mass Index | 11 | 2021 | 867 | 0.480 |
Why?
|
| Image Enhancement | 7 | 2017 | 143 | 0.460 |
Why?
|
| Positron-Emission Tomography | 8 | 2021 | 160 | 0.440 |
Why?
|
| Expert Testimony | 2 | 2012 | 47 | 0.440 |
Why?
|
| Endovascular Procedures | 3 | 2022 | 366 | 0.440 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2012 | 186 | 0.430 |
Why?
|
| Pattern Recognition, Automated | 5 | 2020 | 70 | 0.430 |
Why?
|
| Obesity | 7 | 2021 | 1076 | 0.430 |
Why?
|
| Ventricular Function, Left | 10 | 2023 | 481 | 0.430 |
Why?
|
| Blood Volume | 2 | 2015 | 47 | 0.430 |
Why?
|
| Fabry Disease | 2 | 2022 | 6 | 0.430 |
Why?
|
| Child | 23 | 2021 | 6405 | 0.430 |
Why?
|
| Time Factors | 16 | 2021 | 4655 | 0.420 |
Why?
|
| China | 9 | 2022 | 138 | 0.420 |
Why?
|
| Abdomen | 5 | 2019 | 80 | 0.420 |
Why?
|
| Professional Competence | 1 | 2013 | 100 | 0.410 |
Why?
|
| Myocarditis | 3 | 2020 | 49 | 0.410 |
Why?
|
| Myocardial Reperfusion | 3 | 2011 | 32 | 0.410 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2012 | 5 | 0.410 |
Why?
|
| Treatment Outcome | 16 | 2022 | 7029 | 0.410 |
Why?
|
| Radionuclide Imaging | 5 | 2014 | 166 | 0.400 |
Why?
|
| Hypertrophy, Right Ventricular | 3 | 2011 | 21 | 0.400 |
Why?
|
| United States | 16 | 2021 | 7367 | 0.400 |
Why?
|
| Models, Economic | 1 | 2012 | 69 | 0.400 |
Why?
|
| Mitral Valve | 3 | 2020 | 166 | 0.400 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 300 | 0.390 |
Why?
|
| Vasodilator Agents | 6 | 2017 | 138 | 0.390 |
Why?
|
| Kidney Diseases | 3 | 2014 | 307 | 0.380 |
Why?
|
| Venous Thrombosis | 7 | 2014 | 125 | 0.380 |
Why?
|
| Lumbar Vertebrae | 4 | 2023 | 112 | 0.380 |
Why?
|
| Hospitals, University | 1 | 2011 | 169 | 0.380 |
Why?
|
| Cerebral Angiography | 3 | 2017 | 151 | 0.370 |
Why?
|
| Blood Flow Velocity | 5 | 2018 | 172 | 0.370 |
Why?
|
| Clinical Protocols | 1 | 2011 | 172 | 0.370 |
Why?
|
| Kidney Transplantation | 4 | 2022 | 839 | 0.360 |
Why?
|
| Cohort Studies | 12 | 2022 | 2358 | 0.360 |
Why?
|
| Liver Neoplasms | 5 | 2018 | 334 | 0.360 |
Why?
|
| Brain | 8 | 2017 | 2176 | 0.360 |
Why?
|
| Vascular Diseases | 3 | 2017 | 94 | 0.360 |
Why?
|
| Nephrotic Syndrome | 3 | 2017 | 61 | 0.360 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 142 | 0.360 |
Why?
|
| Comorbidity | 11 | 2019 | 1426 | 0.360 |
Why?
|
| Viscera | 1 | 2010 | 16 | 0.350 |
Why?
|
| Whole-Body Counting | 1 | 2010 | 6 | 0.350 |
Why?
|
| Public Opinion | 1 | 2010 | 32 | 0.350 |
Why?
|
| South Carolina | 8 | 2019 | 2752 | 0.350 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 694 | 0.350 |
Why?
|
| Radiopharmaceuticals | 6 | 2021 | 114 | 0.340 |
Why?
|
| Automation | 4 | 2019 | 45 | 0.340 |
Why?
|
| Pericardium | 3 | 2015 | 97 | 0.340 |
Why?
|
| Physicians | 1 | 2013 | 324 | 0.340 |
Why?
|
| Prosthesis Design | 4 | 2015 | 301 | 0.340 |
Why?
|
| Osmolar Concentration | 4 | 2018 | 134 | 0.330 |
Why?
|
| Myocardial Contraction | 2 | 2015 | 383 | 0.330 |
Why?
|
| Pyrazoles | 3 | 2021 | 190 | 0.330 |
Why?
|
| Absorptiometry, Photon | 3 | 2023 | 83 | 0.330 |
Why?
|
| Hypertension | 2 | 2016 | 1535 | 0.330 |
Why?
|
| Kidney Failure, Chronic | 3 | 2017 | 365 | 0.330 |
Why?
|
| Models, Biological | 2 | 2010 | 981 | 0.330 |
Why?
|
| Creatinine | 2 | 2014 | 243 | 0.320 |
Why?
|
| Betacoronavirus | 2 | 2020 | 116 | 0.320 |
Why?
|
| Abnormalities, Multiple | 3 | 2013 | 109 | 0.320 |
Why?
|
| Terminology as Topic | 4 | 2016 | 141 | 0.320 |
Why?
|
| Defibrillators, Implantable | 2 | 2023 | 329 | 0.320 |
Why?
|
| Chi-Square Distribution | 12 | 2017 | 546 | 0.320 |
Why?
|
| Heart Aneurysm | 3 | 2014 | 21 | 0.320 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2019 | 134 | 0.320 |
Why?
|
| Glomerular Filtration Rate | 2 | 2014 | 274 | 0.320 |
Why?
|
| Odds Ratio | 6 | 2017 | 880 | 0.320 |
Why?
|
| Case-Control Studies | 9 | 2019 | 1553 | 0.310 |
Why?
|
| Child, Preschool | 11 | 2019 | 3187 | 0.310 |
Why?
|
| Aorta, Abdominal | 2 | 2021 | 97 | 0.310 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2008 | 20 | 0.310 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2008 | 15 | 0.310 |
Why?
|
| Mass Screening | 2 | 2012 | 843 | 0.310 |
Why?
|
| Erythrocytes | 1 | 2008 | 137 | 0.300 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 450 | 0.300 |
Why?
|
| Injections, Intravenous | 7 | 2014 | 215 | 0.300 |
Why?
|
| Liver | 7 | 2021 | 1118 | 0.300 |
Why?
|
| Thrombosis | 1 | 2009 | 218 | 0.300 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 10 | 0.300 |
Why?
|
| Ventricular Function, Right | 6 | 2023 | 103 | 0.300 |
Why?
|
| Presenilin-2 | 2 | 2017 | 6 | 0.300 |
Why?
|
| Medical Records | 2 | 2019 | 121 | 0.290 |
Why?
|
| Presenilin-1 | 2 | 2017 | 28 | 0.290 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 143 | 0.290 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2019 | 239 | 0.290 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 154 | 0.290 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2007 | 30 | 0.290 |
Why?
|
| Infant, Newborn | 12 | 2017 | 2455 | 0.290 |
Why?
|
| Vena Cava, Superior | 2 | 2009 | 41 | 0.290 |
Why?
|
| Aortic Aneurysm | 4 | 2016 | 77 | 0.290 |
Why?
|
| Liver Diseases | 3 | 2016 | 193 | 0.280 |
Why?
|
| Arterial Pressure | 3 | 2017 | 47 | 0.280 |
Why?
|
| Respiration | 4 | 2019 | 91 | 0.280 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 225 | 0.280 |
Why?
|
| Cardiology | 3 | 2016 | 140 | 0.280 |
Why?
|
| Infant | 11 | 2019 | 2891 | 0.280 |
Why?
|
| Temperature | 1 | 2008 | 341 | 0.280 |
Why?
|
| Disease Management | 3 | 2020 | 248 | 0.270 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2006 | 15 | 0.270 |
Why?
|
| Syringes | 1 | 2006 | 15 | 0.270 |
Why?
|
| Tomography Scanners, X-Ray Computed | 3 | 2003 | 32 | 0.270 |
Why?
|
| Diagnostic Errors | 2 | 2005 | 100 | 0.260 |
Why?
|
| Hippocampus | 2 | 2021 | 471 | 0.260 |
Why?
|
| Survival Rate | 7 | 2019 | 1056 | 0.260 |
Why?
|
| Hepatic Encephalopathy | 2 | 2016 | 25 | 0.260 |
Why?
|
| Triage | 4 | 2018 | 109 | 0.260 |
Why?
|
| Early Detection of Cancer | 3 | 2021 | 454 | 0.260 |
Why?
|
| Heart Neoplasms | 2 | 2016 | 33 | 0.260 |
Why?
|
| Sodium Chloride | 1 | 2006 | 136 | 0.260 |
Why?
|
| Angina Pectoris | 3 | 2019 | 61 | 0.260 |
Why?
|
| Pilot Projects | 7 | 2021 | 1342 | 0.260 |
Why?
|
| Paranasal Sinuses | 1 | 2007 | 165 | 0.250 |
Why?
|
| Pulmonary Veins | 3 | 2014 | 56 | 0.250 |
Why?
|
| Analysis of Variance | 6 | 2017 | 1040 | 0.250 |
Why?
|
| Clinical Decision-Making | 4 | 2018 | 109 | 0.250 |
Why?
|
| Animals | 17 | 2020 | 20881 | 0.250 |
Why?
|
| Jugular Veins | 2 | 2015 | 37 | 0.240 |
Why?
|
| Disease Progression | 7 | 2021 | 1038 | 0.240 |
Why?
|
| North America | 3 | 2019 | 112 | 0.240 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2017 | 141 | 0.240 |
Why?
|
| Pancreatic Neoplasms | 3 | 2015 | 332 | 0.230 |
Why?
|
| Arterio-Arterial Fistula | 2 | 2013 | 4 | 0.230 |
Why?
|
| Coronary Thrombosis | 3 | 2015 | 45 | 0.230 |
Why?
|
| Purines | 2 | 2021 | 39 | 0.230 |
Why?
|
| Iliac Artery | 2 | 2015 | 44 | 0.230 |
Why?
|
| Logistic Models | 6 | 2018 | 1420 | 0.230 |
Why?
|
| Anticoagulants | 2 | 2021 | 356 | 0.230 |
Why?
|
| User-Computer Interface | 3 | 2017 | 230 | 0.230 |
Why?
|
| Cone-Beam Computed Tomography | 5 | 2019 | 52 | 0.220 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 2021 | 81 | 0.220 |
Why?
|
| Injections | 2 | 2020 | 119 | 0.220 |
Why?
|
| Neuropsychological Tests | 7 | 2021 | 517 | 0.220 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2023 | 30 | 0.210 |
Why?
|
| Recurrence | 3 | 2021 | 948 | 0.210 |
Why?
|
| Sinus of Valsalva | 2 | 2013 | 9 | 0.210 |
Why?
|
| Electronic Health Records | 2 | 2016 | 374 | 0.210 |
Why?
|
| Fibrosis | 3 | 2022 | 371 | 0.210 |
Why?
|
| Clinical Competence | 5 | 2014 | 657 | 0.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2023 | 346 | 0.210 |
Why?
|
| Pelvis | 2 | 2019 | 38 | 0.210 |
Why?
|
| Equipment Design | 7 | 2020 | 500 | 0.210 |
Why?
|
| Reference Standards | 5 | 2022 | 115 | 0.200 |
Why?
|
| Osteoporosis | 1 | 2023 | 88 | 0.200 |
Why?
|
| Hydrodynamics | 2 | 2019 | 15 | 0.200 |
Why?
|
| Genetic Testing | 1 | 2002 | 159 | 0.190 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2021 | 25 | 0.190 |
Why?
|
| Fractures, Compression | 1 | 2021 | 11 | 0.190 |
Why?
|
| Catheter Ablation | 2 | 2020 | 229 | 0.190 |
Why?
|
| Early Diagnosis | 3 | 2017 | 122 | 0.190 |
Why?
|
| Hematoma | 1 | 2021 | 47 | 0.190 |
Why?
|
| Anthracyclines | 1 | 2020 | 9 | 0.190 |
Why?
|
| Endoleak | 1 | 2021 | 23 | 0.190 |
Why?
|
| Italy | 1 | 2020 | 36 | 0.190 |
Why?
|
| Angina, Unstable | 3 | 2016 | 50 | 0.190 |
Why?
|
| Coronary Occlusion | 1 | 2020 | 12 | 0.190 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2012 | 106 | 0.190 |
Why?
|
| Swine | 3 | 2018 | 672 | 0.180 |
Why?
|
| Spinal Fractures | 1 | 2021 | 43 | 0.180 |
Why?
|
| Hospitals, Community | 1 | 2020 | 64 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2021 | 106 | 0.180 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 1046 | 0.180 |
Why?
|
| Vascular Access Devices | 1 | 2020 | 21 | 0.180 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2021 | 77 | 0.180 |
Why?
|
| Time | 1 | 2020 | 57 | 0.180 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 27 | 0.180 |
Why?
|
| Portal Vein | 2 | 2016 | 46 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 161 | 0.170 |
Why?
|
| Leukocytes | 2 | 2010 | 99 | 0.170 |
Why?
|
| Incidence | 7 | 2021 | 1603 | 0.170 |
Why?
|
| Telomere | 2 | 2010 | 59 | 0.170 |
Why?
|
| Tissue Survival | 1 | 2019 | 22 | 0.170 |
Why?
|
| Pandemics | 2 | 2020 | 352 | 0.170 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2015 | 100 | 0.170 |
Why?
|
| Abdominal Neoplasms | 1 | 1999 | 22 | 0.170 |
Why?
|
| Connectome | 1 | 2021 | 92 | 0.170 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2021 | 139 | 0.170 |
Why?
|
| Disease Models, Animal | 9 | 2018 | 2550 | 0.170 |
Why?
|
| Documentation | 2 | 2016 | 83 | 0.170 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 191 | 0.160 |
Why?
|
| Leg | 2 | 2014 | 191 | 0.160 |
Why?
|
| Ultrasonography | 2 | 2015 | 453 | 0.160 |
Why?
|
| Bronchial Neoplasms | 1 | 1998 | 12 | 0.160 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 800 | 0.160 |
Why?
|
| Radiotherapy | 2 | 2017 | 86 | 0.160 |
Why?
|
| Statistics as Topic | 4 | 2015 | 219 | 0.160 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 81 | 0.160 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 2013 | 8 | 0.160 |
Why?
|
| Extracellular Fluid | 1 | 2018 | 29 | 0.160 |
Why?
|
| Aneurysm, False | 2 | 2009 | 60 | 0.160 |
Why?
|
| Robotics | 1 | 2018 | 56 | 0.160 |
Why?
|
| Cell Size | 1 | 2018 | 76 | 0.160 |
Why?
|
| Renal Artery Obstruction | 1 | 2018 | 29 | 0.160 |
Why?
|
| Confidence Intervals | 3 | 2015 | 242 | 0.160 |
Why?
|
| Colonic Neoplasms | 1 | 2001 | 299 | 0.150 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2011 | 50 | 0.150 |
Why?
|
| Reference Values | 3 | 2021 | 579 | 0.150 |
Why?
|
| Carotid Stenosis | 1 | 2019 | 163 | 0.150 |
Why?
|
| Magnetics | 1 | 1998 | 52 | 0.150 |
Why?
|
| Dogs | 5 | 2020 | 490 | 0.150 |
Why?
|
| Oxides | 1 | 1998 | 47 | 0.150 |
Why?
|
| Models, Animal | 1 | 2018 | 252 | 0.150 |
Why?
|
| Linear Models | 4 | 2012 | 521 | 0.150 |
Why?
|
| Renal Veins | 2 | 2014 | 18 | 0.150 |
Why?
|
| Pancreas | 2 | 2015 | 225 | 0.150 |
Why?
|
| Neoplasms | 3 | 2019 | 1667 | 0.150 |
Why?
|
| Proportional Hazards Models | 5 | 2016 | 792 | 0.150 |
Why?
|
| Survival Analysis | 5 | 2015 | 714 | 0.150 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 202 | 0.150 |
Why?
|
| Biomarkers | 6 | 2019 | 1593 | 0.140 |
Why?
|
| Male Urogenital Diseases | 1 | 2017 | 2 | 0.140 |
Why?
|
| Female Urogenital Diseases | 1 | 2017 | 5 | 0.140 |
Why?
|
| Lipids | 1 | 2019 | 298 | 0.140 |
Why?
|
| Sex Factors | 5 | 2021 | 1266 | 0.140 |
Why?
|
| Diabetes Complications | 1 | 2018 | 249 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 1998 | 324 | 0.140 |
Why?
|
| Digestive System Diseases | 1 | 2017 | 16 | 0.140 |
Why?
|
| Bronchoscopy | 1 | 1998 | 147 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2019 | 403 | 0.140 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 80 | 0.140 |
Why?
|
| Positron Emission Tomography Computed Tomography | 3 | 2021 | 38 | 0.140 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 115 | 0.140 |
Why?
|
| Embolism, Fat | 1 | 2016 | 13 | 0.140 |
Why?
|
| Fluorine Radioisotopes | 1 | 2016 | 13 | 0.140 |
Why?
|
| Musculoskeletal Diseases | 1 | 2017 | 45 | 0.140 |
Why?
|
| Hemangiosarcoma | 1 | 2016 | 23 | 0.140 |
Why?
|
| Models, Statistical | 2 | 2011 | 448 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 117 | 0.130 |
Why?
|
| Iron | 1 | 1998 | 197 | 0.130 |
Why?
|
| Organ Size | 5 | 2016 | 242 | 0.130 |
Why?
|
| Information Storage and Retrieval | 1 | 2016 | 49 | 0.130 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 100 | 0.130 |
Why?
|
| Radionuclide Angiography | 1 | 2015 | 2 | 0.130 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2016 | 73 | 0.130 |
Why?
|
| Biopsy, Needle | 2 | 2006 | 191 | 0.130 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 10 | 0.130 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2016 | 28 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 1 | 2017 | 191 | 0.130 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 22 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2018 | 287 | 0.130 |
Why?
|
| Xenon | 2 | 2014 | 4 | 0.130 |
Why?
|
| Probability | 5 | 2019 | 245 | 0.130 |
Why?
|
| Technetium Tc 99m Sestamibi | 2 | 2013 | 24 | 0.130 |
Why?
|
| Cerebral Infarction | 1 | 2016 | 103 | 0.130 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 756 | 0.130 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 92 | 0.130 |
Why?
|
| Sarcoma, Ewing | 1 | 2015 | 26 | 0.130 |
Why?
|
| Thrombolytic Therapy | 2 | 2009 | 233 | 0.130 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 29 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 85 | 0.130 |
Why?
|
| Neck Dissection | 1 | 2015 | 55 | 0.120 |
Why?
|
| Mutation | 2 | 2017 | 1213 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2020 | 1330 | 0.120 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 47 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2016 | 178 | 0.120 |
Why?
|
| Drug Eruptions | 1 | 2014 | 16 | 0.120 |
Why?
|
| Biomedical Research | 2 | 2017 | 310 | 0.120 |
Why?
|
| Cardiac Output | 2 | 2012 | 133 | 0.120 |
Why?
|
| Cancer Survivors | 1 | 2017 | 146 | 0.120 |
Why?
|
| Stochastic Processes | 1 | 2014 | 27 | 0.120 |
Why?
|
| Edema | 1 | 2014 | 66 | 0.120 |
Why?
|
| Funnel Chest | 1 | 2014 | 3 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2014 | 47 | 0.120 |
Why?
|
| Saphenous Vein | 1 | 2014 | 61 | 0.120 |
Why?
|
| Patient Care Planning | 4 | 2016 | 108 | 0.120 |
Why?
|
| Cognition Disorders | 1 | 2017 | 342 | 0.120 |
Why?
|
| Aspergillosis | 1 | 2014 | 20 | 0.120 |
Why?
|
| Amygdala | 1 | 2016 | 159 | 0.120 |
Why?
|
| Aneurysm | 1 | 2014 | 53 | 0.120 |
Why?
|
| After-Hours Care | 1 | 2014 | 17 | 0.120 |
Why?
|
| Breast | 1 | 2015 | 137 | 0.120 |
Why?
|
| Thrombophlebitis | 2 | 2004 | 47 | 0.120 |
Why?
|
| Emotions | 1 | 2016 | 244 | 0.120 |
Why?
|
| Vascular Malformations | 1 | 2014 | 19 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 182 | 0.120 |
Why?
|
| Age Factors | 6 | 2021 | 1864 | 0.120 |
Why?
|
| Cause of Death | 1 | 2015 | 241 | 0.120 |
Why?
|
| Heterotaxy Syndrome | 1 | 2013 | 3 | 0.120 |
Why?
|
| Pulmonary Ventilation | 1 | 2014 | 28 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 296 | 0.120 |
Why?
|
| Pulmonary Atresia | 1 | 2013 | 6 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 119 | 0.110 |
Why?
|
| Williams Syndrome | 1 | 2013 | 13 | 0.110 |
Why?
|
| Movement | 2 | 2019 | 179 | 0.110 |
Why?
|
| Cognition | 1 | 2017 | 513 | 0.110 |
Why?
|
| Tetralogy of Fallot | 1 | 2013 | 43 | 0.110 |
Why?
|
| Neck | 1 | 2013 | 62 | 0.110 |
Why?
|
| Pregnancy | 1 | 2019 | 2334 | 0.110 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 49 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2013 | 110 | 0.110 |
Why?
|
| Head | 1 | 2013 | 59 | 0.110 |
Why?
|
| Evaluation Studies as Topic | 5 | 2019 | 219 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 116 | 0.110 |
Why?
|
| Vascular Stiffness | 1 | 2013 | 31 | 0.110 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2011 | 131 | 0.110 |
Why?
|
| Mammography | 1 | 2015 | 310 | 0.100 |
Why?
|
| Aortic Arch Syndromes | 1 | 2012 | 3 | 0.100 |
Why?
|
| Seizures | 1 | 2014 | 279 | 0.100 |
Why?
|
| Adaptation, Physiological | 2 | 2010 | 189 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 475 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2012 | 91 | 0.100 |
Why?
|
| Vascular Patency | 3 | 2014 | 122 | 0.100 |
Why?
|
| Educational Status | 1 | 2013 | 273 | 0.100 |
Why?
|
| Polysomnography | 1 | 2012 | 92 | 0.100 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2012 | 6 | 0.100 |
Why?
|
| Fistula | 1 | 2012 | 29 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2012 | 117 | 0.100 |
Why?
|
| Risk | 2 | 2014 | 563 | 0.100 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 17 | 0.100 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2011 | 3 | 0.100 |
Why?
|
| Heart Injuries | 1 | 2011 | 25 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 82 | 0.100 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 45 | 0.100 |
Why?
|
| Discrete Subaortic Stenosis | 1 | 2011 | 3 | 0.100 |
Why?
|
| Single-Blind Method | 2 | 2013 | 249 | 0.100 |
Why?
|
| Models, Cardiovascular | 3 | 2019 | 133 | 0.090 |
Why?
|
| Emergencies | 1 | 2011 | 107 | 0.090 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 320 | 0.090 |
Why?
|
| Aging | 2 | 2014 | 911 | 0.090 |
Why?
|
| LEOPARD Syndrome | 1 | 2010 | 2 | 0.090 |
Why?
|
| Atrial Function | 1 | 2010 | 8 | 0.090 |
Why?
|
| Health Policy | 1 | 2012 | 221 | 0.090 |
Why?
|
| Syncope | 2 | 2014 | 23 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 140 | 0.090 |
Why?
|
| Athletes | 1 | 2010 | 40 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 90 | 0.090 |
Why?
|
| Soccer | 1 | 2010 | 13 | 0.090 |
Why?
|
| Dilatation, Pathologic | 2 | 2021 | 58 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 250 | 0.090 |
Why?
|
| Mass Media | 1 | 2010 | 29 | 0.090 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2010 | 14 | 0.090 |
Why?
|
| Cardiac Volume | 1 | 2010 | 21 | 0.090 |
Why?
|
| Sternotomy | 1 | 2009 | 18 | 0.090 |
Why?
|
| Sternum | 1 | 2009 | 19 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 629 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 536 | 0.090 |
Why?
|
| Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2009 | 2 | 0.090 |
Why?
|
| Consensus | 3 | 2016 | 211 | 0.090 |
Why?
|
| Regression Analysis | 4 | 2013 | 737 | 0.080 |
Why?
|
| Brain Mapping | 3 | 2017 | 532 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 191 | 0.080 |
Why?
|
| Technology, Pharmaceutical | 1 | 2009 | 8 | 0.080 |
Why?
|
| Pharmacokinetics | 1 | 2009 | 14 | 0.080 |
Why?
|
| Water | 1 | 2010 | 230 | 0.080 |
Why?
|
| Depression | 1 | 2016 | 943 | 0.080 |
Why?
|
| Heterozygote | 2 | 2021 | 174 | 0.080 |
Why?
|
| Fear | 1 | 2010 | 239 | 0.080 |
Why?
|
| Warfarin | 1 | 2009 | 93 | 0.080 |
Why?
|
| Asymptomatic Diseases | 2 | 2019 | 43 | 0.080 |
Why?
|
| Lymph Nodes | 2 | 2021 | 258 | 0.080 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2008 | 33 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2014 | 596 | 0.080 |
Why?
|
| Papillary Muscles | 1 | 2008 | 30 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2010 | 706 | 0.080 |
Why?
|
| Life Style | 1 | 2010 | 338 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2008 | 102 | 0.080 |
Why?
|
| Cocaine-Related Disorders | 1 | 2013 | 504 | 0.080 |
Why?
|
| Rest | 2 | 2019 | 78 | 0.080 |
Why?
|
| Isolated Heart Preparation | 2 | 2018 | 8 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 261 | 0.080 |
Why?
|
| Ischemia | 2 | 2022 | 229 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2009 | 123 | 0.080 |
Why?
|
| Sus scrofa | 2 | 2018 | 74 | 0.080 |
Why?
|
| Relative Biological Effectiveness | 1 | 2007 | 10 | 0.070 |
Why?
|
| Filtration | 2 | 2018 | 61 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1536 | 0.070 |
Why?
|
| Myocardial Revascularization | 2 | 2017 | 56 | 0.070 |
Why?
|
| Abdomen, Acute | 1 | 2007 | 14 | 0.070 |
Why?
|
| Buttocks | 1 | 2006 | 16 | 0.070 |
Why?
|
| Health Behavior | 1 | 2010 | 458 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 371 | 0.070 |
Why?
|
| Equipment Failure Analysis | 2 | 2016 | 121 | 0.070 |
Why?
|
| Hospital Charges | 1 | 2006 | 60 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2006 | 41 | 0.070 |
Why?
|
| Causality | 2 | 2017 | 82 | 0.070 |
Why?
|
| Phlebography | 1 | 2005 | 31 | 0.060 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2006 | 47 | 0.060 |
Why?
|
| Mathematics | 1 | 2005 | 83 | 0.060 |
Why?
|
| Life Tables | 1 | 2004 | 29 | 0.060 |
Why?
|
| Syndrome | 3 | 2012 | 255 | 0.060 |
Why?
|
| Syncope, Vasovagal | 1 | 2004 | 5 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 41 | 0.060 |
Why?
|
| Aerospace Medicine | 1 | 2004 | 22 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1054 | 0.060 |
Why?
|
| Rats | 3 | 2016 | 5300 | 0.060 |
Why?
|
| Hospitalization | 2 | 2021 | 978 | 0.060 |
Why?
|
| Length of Stay | 1 | 2006 | 780 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2673 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2022 | 14 | 0.050 |
Why?
|
| Lymphatic Metastasis | 2 | 2015 | 274 | 0.050 |
Why?
|
| Matched-Pair Analysis | 2 | 2013 | 25 | 0.050 |
Why?
|
| Tomography | 1 | 2022 | 9 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2005 | 238 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 89 | 0.050 |
Why?
|
| X-Rays | 1 | 2022 | 56 | 0.050 |
Why?
|
| Color | 2 | 2016 | 50 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 1 | 2003 | 182 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 130 | 0.050 |
Why?
|
| Radiology, Interventional | 2 | 2017 | 21 | 0.050 |
Why?
|
| Swine, Miniature | 2 | 2011 | 45 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2279 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2021 | 42 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 50 | 0.050 |
Why?
|
| Acceleration | 1 | 2021 | 37 | 0.050 |
Why?
|
| Muscles | 1 | 2021 | 158 | 0.050 |
Why?
|
| Heart Function Tests | 2 | 2011 | 33 | 0.050 |
Why?
|
| Reoperation | 2 | 2014 | 467 | 0.050 |
Why?
|
| Inpatients | 1 | 2022 | 208 | 0.050 |
Why?
|
| World Health Organization | 1 | 2020 | 53 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 778 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 137 | 0.040 |
Why?
|
| Patient Discharge | 2 | 2012 | 294 | 0.040 |
Why?
|
| Thoracic Arteries | 1 | 1999 | 10 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 198 | 0.040 |
Why?
|
| Episode of Care | 1 | 2019 | 12 | 0.040 |
Why?
|
| Mesenteric Arteries | 1 | 1999 | 29 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 83 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1999 | 51 | 0.040 |
Why?
|
| Sphingolipids | 1 | 2022 | 337 | 0.040 |
Why?
|
| Arteries | 1 | 2000 | 108 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 185 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2010 | 765 | 0.040 |
Why?
|
| Bone Wires | 1 | 2018 | 8 | 0.040 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1998 | 18 | 0.040 |
Why?
|
| Calibration | 2 | 2011 | 73 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 110 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 1998 | 40 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 38 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 117 | 0.040 |
Why?
|
| Ferrosoferric Oxide | 1 | 1998 | 10 | 0.040 |
Why?
|
| Renal Artery | 1 | 2018 | 29 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 52 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1998 | 67 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2018 | 46 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 2017 | 30 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 1999 | 206 | 0.040 |
Why?
|
| Efferent Pathways | 1 | 2017 | 15 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 947 | 0.040 |
Why?
|
| Auditory Pathways | 1 | 2017 | 20 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2017 | 31 | 0.040 |
Why?
|
| Endocytosis | 1 | 1998 | 113 | 0.040 |
Why?
|
| Particle Size | 1 | 1998 | 201 | 0.040 |
Why?
|
| Apolipoprotein E2 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2017 | 9 | 0.040 |
Why?
|
| Propensity Score | 1 | 2017 | 117 | 0.040 |
Why?
|
| Neuroradiography | 1 | 2017 | 2 | 0.040 |
Why?
|
| Dimensional Measurement Accuracy | 1 | 2017 | 3 | 0.040 |
Why?
|
| Spleen | 1 | 1998 | 301 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2017 | 25 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 1998 | 261 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.040 |
Why?
|
| Absorption, Radiation | 1 | 2016 | 4 | 0.040 |
Why?
|
| Breath Holding | 1 | 2016 | 8 | 0.040 |
Why?
|
| Hepatic Artery | 1 | 2016 | 25 | 0.040 |
Why?
|
| Forms and Records Control | 1 | 2016 | 16 | 0.040 |
Why?
|
| Auditory Perception | 1 | 2017 | 89 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 168 | 0.030 |
Why?
|
| Biotechnology | 1 | 2016 | 34 | 0.030 |
Why?
|
| Executive Function | 1 | 2017 | 106 | 0.030 |
Why?
|
| Hematemesis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Visual Perception | 1 | 2017 | 124 | 0.030 |
Why?
|
| Ibuprofen | 1 | 2016 | 30 | 0.030 |
Why?
|
| Hemoptysis | 1 | 2016 | 28 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 509 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2015 | 5 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 89 | 0.030 |
Why?
|
| Attention | 1 | 2017 | 225 | 0.030 |
Why?
|
| Systole | 1 | 2015 | 149 | 0.030 |
Why?
|
| Education, Medical | 2 | 2007 | 147 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 114 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 78 | 0.030 |
Why?
|
| Cell Survival | 1 | 1998 | 901 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2017 | 324 | 0.030 |
Why?
|
| Autopsy | 1 | 2014 | 56 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2016 | 174 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 24 | 0.030 |
Why?
|
| Acute Chest Syndrome | 1 | 2014 | 19 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 279 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 34 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2020 | 665 | 0.030 |
Why?
|
| Data Collection | 1 | 2016 | 420 | 0.030 |
Why?
|
| Middle Cerebral Artery | 1 | 2015 | 57 | 0.030 |
Why?
|
| Scimitar Syndrome | 1 | 2014 | 6 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 2014 | 41 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 567 | 0.030 |
Why?
|
| Carotid Artery, Internal | 1 | 2015 | 85 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 164 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 301 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2014 | 27 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 274 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2015 | 122 | 0.030 |
Why?
|
| Motor Activity | 1 | 2017 | 621 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 320 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 506 | 0.030 |
Why?
|
| Necrosis | 1 | 2014 | 239 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 240 | 0.030 |
Why?
|
| Software Design | 1 | 2013 | 18 | 0.030 |
Why?
|
| Dyspnea | 1 | 2014 | 87 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 786 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2015 | 211 | 0.030 |
Why?
|
| Fatigue | 1 | 2014 | 132 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 334 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2014 | 187 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2013 | 25 | 0.030 |
Why?
|
| Ligation | 1 | 2013 | 83 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 64 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 597 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2013 | 145 | 0.030 |
Why?
|
| Biopsy | 1 | 2014 | 540 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 565 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2012 | 42 | 0.030 |
Why?
|
| Troponin I | 1 | 2011 | 34 | 0.020 |
Why?
|
| Atrial Function, Left | 1 | 2011 | 10 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2011 | 101 | 0.020 |
Why?
|
| Computer Systems | 1 | 2010 | 42 | 0.020 |
Why?
|
| Catheterization | 1 | 2011 | 209 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1745 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2010 | 38 | 0.020 |
Why?
|
| Diastole | 1 | 2010 | 161 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 2011 | 101 | 0.020 |
Why?
|
| Tracheal Stenosis | 1 | 2009 | 21 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2010 | 127 | 0.020 |
Why?
|
| Metals | 1 | 2010 | 100 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2011 | 483 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2010 | 248 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 263 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2009 | 76 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2008 | 21 | 0.020 |
Why?
|
| Stroke | 1 | 2020 | 2163 | 0.020 |
Why?
|
| Social Support | 1 | 2010 | 423 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 318 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2008 | 109 | 0.020 |
Why?
|
| Diet | 1 | 2010 | 514 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 1452 | 0.020 |
Why?
|
| Cadaver | 1 | 2006 | 136 | 0.020 |
Why?
|
| Mice | 1 | 1998 | 8474 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2005 | 24 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 87 | 0.020 |
Why?
|
| Exercise | 1 | 2010 | 658 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2004 | 186 | 0.010 |
Why?
|
| Politics | 1 | 2003 | 31 | 0.010 |
Why?
|
| Medicine | 1 | 2003 | 52 | 0.010 |
Why?
|
| Pulse | 1 | 2002 | 23 | 0.010 |
Why?
|
| Electrons | 1 | 2000 | 25 | 0.010 |
Why?
|
| Ceramics | 1 | 1999 | 23 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2002 | 384 | 0.010 |
Why?
|
| Computers | 1 | 1998 | 63 | 0.010 |
Why?
|